Scott W. Drake has served as our President and Chief Executive Officer and as a member of our board of directors since July 2018. Mr. Drake has over 30 years of experience in the medical device field. From August 2011 to August 2017, he served as President and Chief Executive Officer, and as a member of the board of directors of The Spectranetics Corporation (NASDAQ: SPNC), a medical device company. From November 2009 to July 2011, he was a Senior Vice President of DaVita Corporation (NYSE: DVA), a provider of kidney care and dialysis. Mr. Drake served on the board of directors of Paragon 28, Inc. (NYSE: FNA) a medical device manufacturer, from August 2021 to August 2022. Mr. Drake served as the Chairman of the Board of AtriCure, Inc. (NASDAQ: ATRC) from 2013 to April 2021, as well as a member of the board of directors of Zayo Group Holdings, Inc. (NYSE: ZAYO) from November 2018 to March 2020. He has served on the board of directors of Cordis, a privately held medical device manufacturer, since August 2021. He serves as the Chairperson of the AdvaMed Radiation Therapy Sector as well as a board member for the Medical Device Manufacturers Association (MDMA). Mr. Drake holds a B.S. in Business Administration from Miami University of Ohio.

Paul Ziegler is Executive Vice President and Chief Commercial Officer at ViewRay, where he is leading the charge to drive adoption of the MRIdian system. With more than 19 years of experience in the medical device space, Ziegler has proven success in commercializing paradigm-changing technologies. As a global, strategic leader, he brings multi-disciplinary experience managing all functional areas including marketing, product innovation, portfolio strategy and go-to-market execution; Ziegler has led complex businesses to deliver superior results across all product lifecycles. Prior to joining ViewRay, he served as Vice President of Sales for TransEnterix, leading commercialization efforts for the surgical robotics platform, Senhance. His experience also includes more than nine years at Intuitive Surgical and roles at CardioVations and Dianon/LabCorp. He learned leadership and discipline in his eight years in the U.S. Navy, holds a B.A. from Norwich University in Northfield, VT and a J.D. from William and Mary in Williamsburg, VA.

James F. Dempsey, Ph.D. has served as our Chief Scientific Officer since founding ViewRay in March 2004. Dr. Dempsey brings more than 23 years of experience in the field of radiotherapy medical physics to ViewRay. He previously served as a faculty member in the University of Florida Department of Radiation Oncology, as Assistant Professor from July 2001 to July 2007 and Associate Professor from July 2007 to January 2008. Dr. Dempsey holds a B.S. in Radiochemistry from San Jose State University and a Ph.D. in Nuclear Chemistry from Washington University in St. Louis.

Dr. Martin Fuss is Chief Medical Officer and the Executive Director of the Clinical Cooperative Think Tank (C2T2) as well as a practicing radiation oncologist and partner in Radiation Oncology Specialists in Tualatin, OR. Dr. Fuss graduated from medical school at the University of Heidelberg, Germany where he also obtained his doctorate degree in human imaging assessing blood flow changes in the brain using functional MRI techniques (DCE-MRI). He underwent his specialty training in radiation oncology at the University of Heidelberg and at the German Cancer Research Center (dkfz). During his residency, he was invited as a research fellow at the Proton Radiation Therapy facility at Loma Linda University Medical Center in Loma Linda, CA. From 2000 to 2006 he was a faculty member at The University of Texas Health Science Center at San Antonio, San Antonio, TX (UTHSCSA). Prior to moving into private practice, he was Professor and Vice Chair of the Department of Radiation Medicine at Oregon Health & Science University (OHSU) from 2006-2013.

Rob Fuchs joined ViewRay as Chief Human Resources Officer in October of 2018, bringing more than 25 years of human resource leadership in the medical device, high-tech, telecommunications, and service industries. He most recently served as the Senior Vice President, Global Human Resources Officer for Advanced Energy. Previously, Fuchs served as the Senior Vice President, Global Human Resources at Spectranetics Corporation in Colorado Springs, Colorado. In this role, he led all aspects of human resources. Prior to his role at Spectranetics, he worked for over 13 years at Echostar Communications and DISH Network, public sister companies in Englewood, Colorado. During his tenure there, he held a variety of human resources leadership roles. Mr. Fuchs has a bachelor of science in business and marketing from Ithaca College.

Robert McCormack joined ViewRay as Senior Vice President, General Counsel and Corporate Secretary in August 2018. He has worked in the medical device and IT industries since 2008. Prior to that, Mr. McCormack worked in private practice in Denver, Colorado, where he focused on corporate, securities, mergers and acquisitions, and general business matters. Mr. McCormack holds a JD from the University of Denver, College of Law and a BS in Finance from Metropolitan State University of Denver.

William P. Burke was appointed as our Executive Vice President and Chief Financial Officer in January 2023. Previously, Mr. Burke served as Executive Vice President and Chief Financial Officer for Haemonetics Corporation, a global blood management solutions company, from August 2016 to April 2022 and stayed on in an advisory capacity through June 2022. From July 2014 to July 2016, he served as Chief Integration Officer and Vice President, Integration for Medtronic, plc, a global healthcare products company and was a member of its Executive Committee. In that role, Mr. Burke was responsible for ensuring the successful integration of Medtronic with Covidien plc, a global healthcare company, following its acquisition by Medtronic. Prior to joining Medtronic, he spent more than 20 years in finance and business development leadership roles at Covidien, including Chief Financial Officer for Covidien Europe based in Zurich, Vice President of Corporate Strategy and Portfolio Management and Vice President of Financial Planning and Analysis. Since January 2022 Mr. Burke has served on the board of directors and as audit committee chair of MiroMatrix (Nasdaq: MIRO), a life sciences company and since July 2022, he has served on the board of directors and as audit committee chair of Axogen (Nasdaq: AXGN), a surgical solutions company. Previously, Mr. Burke also held key positions within Tyco Healthcare, including the Financial Controller of Valleylab, Managing Director of the Covidien Group in Switzerland and International Controller. He began his career as an auditor with KPMG. Mr. Burke received a Bachelor of Science degree in Business Administration from Bryant College.

Amanda Williams joined ViewRay in October of 2018 and brings 20 years of experience in the medical device space. She has been in various leadership roles across clinical, quality and regulatory with Philips Image Guided Therapy division, Spectrantics and AGA Medical (now part of Abbott). At Spectranetics, she led teams that completed multiple global randomized clinical studies. These were successful in driving regulatory approvals allowing market access for strategic business initiatives. One of these studies achieved a first of its kind indication for use with the FDA for the U.S market. She holds a Masters of Science in Regulatory from Northeastern University and a Bachelors of Science in Chemistry from the University of Minnesota.

Drew Hill joined ViewRay in 2018 and brings more than 15 years of experience in Operations across the medical device, pharmaceutical, and consumer products space. Prior to joining ViewRay, Drew was the Director of Operations of the Colorado Springs location of Philips Image Guided Therapy, formerly Spectranetics, and prior to Spectranetics Drew held various roles at GSK Vaccines, formerly Novartis Vaccines. Drew holds an MBA and a SM in Chemical Engineering from the Massachusetts Institute of Technology and a BS in Chemical Engineering from the University of Florida.

Adam Podbelski is Senior Vice President of Global Customer Services at ViewRay, where he and the Global Services leadership team are focused on radically delighting MRIdian customers. With over 20 years of medical device experience that spans product development, program management, commercial execution, and business development, Adam brings a vast background that guides how ViewRay meets its expanding customer base’s needs. Prior to joining ViewRay, Adam held various leadership roles at Philips, Spectranetics, and Medtronic.

Steven Annen joined ViewRay in 2019 and brings more than 25 years of experience in marketing, product, and business development across the medical device and life sciences space. Before joining ViewRay, Steven was the Vice President of Product Management and Strategy of Invuity, Inc. Prior to Invuity Steven held various leadership roles in marketing and strategy at Grabit, Intuitive Surgical, Veeco Instruments, and Omron. Steven holds a Master’s in Mechanical Engineering from the University of Wisconsin-Madison and a Bachelor’s in Mechanical Engineering from Rutgers University.